Gilead will be history three years from now. And no Faucis or Hahns will help it. Leronlimab is not "better than" Remdesivir. Leronlimab is in entirely different league of its own. Once the world medical community and millions of their patients who suffer from terrible and incurable deceases learn about this miracle drug no force in the world will stop it. And btw US doctors is one of the wealthiest professional group of investors in the US. They are in the know and as more and more of them will be buying CYDY the percentage of committed longs will increase and give the SP more stability. Until then, the investing herd's rule of the thumb--buy the rumor, sell the news--will wreak havoc on our SP time and again.
(4)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.